Lukas Hainz

Massachusetts Biomedical Initiatives (MBI) has emerged as a notable force in biotech innovation through its groundbreaking Spark program, which highlights how startups are reshaping medical innovations. This nonprofit biotech accelerator recently concluded its eight-week program with outstanding

In the ever-evolving landscape of cancer therapies, one of the most significant breakthroughs has been the use of monoclonal antibodies and immune checkpoint inhibitors (ICIs). These therapies aim to enhance the immune system's ability to recognize and eliminate tumors. However, the effectiveness

In a significant advance for regenerative medicine, InGeneron, Inc., a biotech leader in autologous regenerative cell therapies, announced a pivotal development in tendon repair. The breakthrough emerged from a recently published study in the International Journal of Molecular Sciences,

The landscape of drug discovery, particularly for complex neurodegenerative diseases like ALS (Amyotrophic Lateral Sclerosis), is undergoing rapid transformation with the advent of artificial intelligence. Louisiana is making significant strides in this arena with the inception of the Louisiana AI

Menstrual blood, often considered merely a byproduct of a natural biological process, is gaining attention as a potential source for health diagnostics. This innovative approach to using menstrual blood, rather than traditional venipuncture blood tests, opens new avenues for understanding and

In the evolving landscape of medical imaging, technological advancement holds immense potential in transforming global healthcare outcomes. Dr. Ge Wang stands at the forefront of this transformation, contributing significantly through his work in X-ray computed tomography (CT) and artificial

The realm of drug discovery has always been a complex, costly, and time-consuming endeavor, with high failure rates due to intrinsic complexities. Among the pivotal challenges is the need to meticulously screen thousands or even millions of molecules to identify one with the desired therapeutic

In Westbury, New York, an MRI machine claimed the life of Keith McAllister, a 61-year-old man, prompting a serious reevaluation of the safety protocols governing such powerful diagnostic tools. On July 16, an ordinary medical appointment took a tragic turn when McAllister, adorned with a 20-pound

In the quest to combat cancer, innovation sits at the heart of every breakthrough. The relentless pursuit of effective therapies has led scientists on a path filled with challenges and triumphs. As many grapple with diseases like intrahepatic cholangiocarcinoma, breast and bladder cancers,

In the realm of pharmaceutical research, decentralized clinical trials (DCTs) are emerging as a transformative force, promising to redefine how clinical studies are conducted. These trials address the traditional challenges that have long plagued clinical research, including limited participant